Chantereau M J, Faivre J, Boutron M C, Piard F, Arveux P, Bedenne L, Hillon P
Registre des Tumeurs, Digestives (Equipe associée INSERM-DGS), Faculté de Médecine, Dijon, France.
Gut. 1992 Feb;33(2):259-63. doi: 10.1136/gut.33.2.259.
The population based registry of digestive tract tumours established for the department of Côte d'Or, France (population 480,000) was used to study the epidemiology and management of malignant large bowel polyps. In a 10 year period (1976-85), 146 cases were recorded in the area. Age standardised incidence rates were 2.7 per 100,000 for men and 1.4 per 100,000 for women. Although incidence rates increased significantly during the study period, large bowel cancer diagnosed as a malignant polyp remained relatively rare (6.2% of all registered large bowel cancers). Two malignant polyps (1.4%) were less than 1 cm in diameter, 34 (23.3%) were more than 30 mm. Sixty patients were treated by endoscopic polypectomy, four by contact radiotherapy, 21 by surgical local excision, 58 by colectomy (10 preceded by polypectomy), and three by colotomy. Operative mortality was 8.2% after intra-abdominal surgery, 4.8% after local surgical excision, and 0% after polypectomy (p less than 0.05). All deaths occurred in patients over 65 years. The five year cumulative recurrence rates were 8.9% after surgical excision and 11.3% after endoscopic polypectomy (NS). The corresponding five year net survival rates were 86.1% and 95.9%. Endoscopic excision alone can be considered a sufficient treatment for adenomas with malignant change unless there is evidence of incomplete resection or a high risk of lymph node metastases.
为法国科多尔省(人口48万)设立的基于人群的消化道肿瘤登记处,被用于研究恶性大肠息肉的流行病学及治疗情况。在10年期间(1976 - 1985年),该地区记录了146例病例。年龄标准化发病率男性为每10万人2.7例,女性为每10万人1.4例。尽管在研究期间发病率显著上升,但诊断为恶性息肉的大肠癌仍然相对少见(占所有登记的大肠癌的6.2%)。两个恶性息肉(1.4%)直径小于1厘米,34个(23.3%)直径大于30毫米。60例患者接受了内镜下息肉切除术,4例接受了接触放射治疗,21例接受了手术局部切除,58例接受了结肠切除术(其中10例术前进行了息肉切除术),3例接受了结肠切开术。腹部手术后手术死亡率为8.2%,局部手术切除后为4.8%,息肉切除术后为0%(p<0.05)。所有死亡均发生在65岁以上患者中。手术切除后五年累积复发率为8.9%,内镜下息肉切除术后为11.3%(无显著差异)。相应的五年净生存率分别为86.1%和95.9%。除非有切除不完全或淋巴结转移高风险的证据,单纯内镜切除可被视为对伴有恶变的腺瘤的充分治疗。